Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.
Binamé F, Pham-Van LD, Spenlé C, Jolivel V, Birmpili D, Meyer LA, Jacob L, Meyer L, Mensah-Nyagan AG, Po C, Van der Heyden M, Roussel G, Bagnard D.
Binamé F, et al. Among authors: bagnard d.
EMBO Mol Med. 2019 Nov 7;11(11):e10378. doi: 10.15252/emmm.201910378. Epub 2019 Sep 30.
EMBO Mol Med. 2019.
PMID: 31566924
Free PMC article.